|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 2 (July 15), 1999:
pp. 649-662
Src-Dependence and Pertussis-Toxin Sensitivity of Urokinase
Receptor-Dependent Chemotaxis and Cytoskeleton Reorganization in
Rat Smooth Muscle Cells
Bernard Degryse,
Massimo Resnati,
Shafaat A. Rabbani,
Antonello Villa,
Francesca Fazioli, and
Francesco Blasi
From DIBIT, Università Vita-Salute San Raffaele, Milano, Italy;
McGill University and Royal Victoria Hospital, Montreal, Quebec,
Canada; and the Dipartimento di Farmacologia, CNR and B. Ceccarelli
Centers, University of Milan.
The catalytically inactive precursor of urokinase-type plasminogen
activator (pro-u-PA) induced a chemotactic response in rat smooth
muscle cells (RSMC) through binding to the membrane receptor of
urokinase (u-PA receptor [u-PAR]). A soluble form of
u-PAR activated by chymotrypsin cleavage as well as a peptide located
between domain 1 and 2 of u-PAR reproduced the effect of pro-u-PA on
cell migration. The chemotactic pro-u-PA effect correlates with a
dramatic reorganization of actin cytoskeleton, of adhesion plaques, and
with major cell shape changes in RSMC. Pro-u-PA induced a decrease in
stress fiber content, membrane ruffling, actin ring formation, and
disruption leading to the characteristic elongated cell shape of motile
cells with an actin semi-ring located close to the leading edge of
cells. u-PAR effects on both chemotaxis and cytoskeleton were sensitive
to pertussis toxin and, hence, possibly require G proteins. u-PAR
effects are accompanied by a relocation of u-PAR, vitronectin receptor
(VNR) v 3, 1 integrin subunit, and Src tyrosine kinase to the
leading membrane of migrating cells. In conclusion, our data show that pro-u-PA, via binding to u-PAR, controls a signaling pathway, regulated
by tyrosine kinases and possibly G proteins, leading to cell
cytoskeleton reorganization and cell migration.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. P. Lillis, L. B. Van Duyn, J. E. Murphy-Ullrich, and D. K. Strickland
LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies
Physiol Rev,
July 1, 2008;
88(3):
887 - 918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. K. Pulukuri, B. Gorantla, and J. S. Rao
Inhibition of Histone Deacetylase Activity Promotes Invasion of Human Cancer Cells through Activation of Urokinase Plasminogen Activator
J. Biol. Chem.,
December 7, 2007;
282(49):
35594 - 35603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Elia, E. Cassol, N. Sidenius, F. Blasi, A. Castagna, G. Poli, and M. Alfano
Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion
J. Leukoc. Biol.,
November 1, 2007;
82(5):
1212 - 1220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Day, Y. H. Lee, A.-M. Park, and Y. J. Suzuki
Retinoic Acid Inhibits Airway Smooth Muscle Cell Migration
Am. J. Respir. Cell Mol. Biol.,
June 1, 2006;
34(6):
695 - 703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mazzieri, S. D'Alessio, R. K. Kenmoe, L. Ossowski, and F. Blasi
An Uncleavable uPAR Mutant Allows Dissection of Signaling Pathways in uPA-dependent Cell Migration
Mol. Biol. Cell,
January 1, 2006;
17(1):
367 - 378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Campagnolo, A. Leahy, S. Chitnis, S. Koschnick, M. J. Fitch, J. T. Fallon, D. Loskutoff, M. B. Taubman, and H. Stuhlmann
EGFL7 Is a Chemoattractant for Endothelial Cells and Is Up-Regulated in Angiogenesis and Arterial Injury
Am. J. Pathol.,
July 1, 2005;
167(1):
275 - 284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Degryse, M. Resnati, R.-P. Czekay, D. J. Loskutoff, and F. Blasi
Domain 2 of the Urokinase Receptor Contains an Integrin-interacting Epitope with Intrinsic Signaling Activity: GENERATION OF A NEW INTEGRIN INHIBITOR
J. Biol. Chem.,
July 1, 2005;
280(26):
24792 - 24803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jo, K. S. Thomas, N. Marozkina, T. J. Amin, C. M. Silva, S. J. Parsons, and S. L. Gonias
Dynamic Assembly of the Urokinase-type Plasminogen Activator Signaling Receptor Complex Determines the Mitogenic Activity of Urokinase-type Plasminogen Activator
J. Biol. Chem.,
April 29, 2005;
280(17):
17449 - 17457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Li, X. Ye, C. Mahanivong, D. Bian, J. Chun, and S. Huang
Signaling Mechanisms Responsible for Lysophosphatidic Acid-induced Urokinase Plasminogen Activator Expression in Ovarian Cancer Cells
J. Biol. Chem.,
March 18, 2005;
280(11):
10564 - 10571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Maupas-Schwalm, C. Robinet, N. Auge, J.-C. Thiers, V. Garcia, J.-P. Cambus, R. Salvayre, and A. Negre-Salvayre
Activation of the {beta}-Catenin/T-Cell-Specific Transcription Factor/Lymphoid Enhancer Factor-1 Pathway by Plasminogen Activators in ECV304 Carcinoma Cells
Cancer Res.,
January 15, 2005;
65(2):
526 - 532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yu, D. Bian, C. Mahanivong, R. K. Cheng, W. Zhou, and S. Huang
p38 Mitogen-activated Protein Kinase Regulation of Endothelial Cell Migration Depends on Urokinase Plasminogen Activator Expression
J. Biol. Chem.,
November 26, 2004;
279(48):
50446 - 50454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. B. Patel
Single Transmembrane Spanning Heterotrimeric G Protein-Coupled Receptors and Their Signaling Cascades
Pharmacol. Rev.,
September 1, 2004;
56(3):
371 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Degryse, J. G. Neels, R.-P. Czekay, K. Aertgeerts, Y.-i. Kamikubo, and D. J. Loskutoff
The Low Density Lipoprotein Receptor-related Protein Is a Motogenic Receptor for Plasminogen Activator Inhibitor-1
J. Biol. Chem.,
May 21, 2004;
279(21):
22595 - 22604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, L. Yang, Md. S. Jamaluddin, and D. D. Boyd
The Kruppel-like KLF4 Transcription Factor, a Novel Regulator of Urokinase Receptor Expression, Drives Synthesis of This Binding Site in Colonic Crypt Luminal Surface Epithelial Cells
J. Biol. Chem.,
May 21, 2004;
279(21):
22674 - 22683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jo, K. S. Thomas, L. Wu, and S. L. Gonias
Soluble Urokinase-type Plasminogen Activator Receptor Inhibits Cancer Cell Growth and Invasion by Direct Urokinase-independent Effects on Cell Signaling
J. Biol. Chem.,
November 21, 2003;
278(47):
46692 - 46698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bdeir, A. Kuo, B. S. Sachais, A. H. Rux, Y. Bdeir, A. Mazar, A. A.-R. Higazi, and D. B. Cines
The kringle stabilizes urokinase binding to the urokinase receptor
Blood,
November 15, 2003;
102(10):
3600 - 3608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Alfano, N. Sidenius, F. Blasi, and G. Poli
The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection
J. Leukoc. Biol.,
November 1, 2003;
74(5):
750 - 756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Carlin, M. Roth, and J. L. Black
Urokinase potentiates PDGF-induced chemotaxis of human airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol,
June 1, 2003;
284(6):
L1020 - L1026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Palmieri, S. Poggi, V. Ulivi, G. Casartelli, and P. Manduca
Pro-collagen I COOH-terminal Trimer Induces Directional Migration and Metalloproteinases in Breast Cancer Cells
J. Biol. Chem.,
January 31, 2003;
278(6):
3639 - 3647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jo, K. S. Thomas, D. M. O'Donnell, and S. L. Gonias
Epidermal Growth Factor Receptor-dependent and -independent Cell-signaling Pathways Originating from the Urokinase Receptor
J. Biol. Chem.,
January 10, 2003;
278(3):
1642 - 1646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Han, J. Leng, D. Bian, C. Mahanivong, K. A. Carpenter, Z. K. Pan, J. Han, and S. Huang
Rac1-MKK3-p38-MAPKAPK2 Pathway Promotes Urokinase Plasminogen Activator mRNA Stability in Invasive Breast Cancer Cells
J. Biol. Chem.,
December 6, 2002;
277(50):
48379 - 48385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Orr, M. A. Pallero, and J. E. Murphy-Ullrich
Thrombospondin Stimulates Focal Adhesion Disassembly through Gi- and Phosphoinositide 3-Kinase-dependent ERK Activation
J. Biol. Chem.,
May 31, 2002;
277(23):
20453 - 20460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Rabbani and J. Gladu
Urokinase Receptor Antibody Can Reduce Tumor Volume and Detect the Presence of Occult Tumor Metastases in Vivo
Cancer Res.,
April 1, 2002;
62(8):
2390 - 2397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jo, K. S. Thomas, A. V. Somlyo, A. P. Somlyo, and S. L. Gonias
Cooperativity between the Ras-ERK and Rho-Rho Kinase Pathways in Urokinase-type Plasminogen Activator-stimulated Cell Migration
J. Biol. Chem.,
March 29, 2002;
277(14):
12479 - 12485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sturge, J. Hamelin, and G. E. Jones
N-WASP activation by a {beta}1-integrin-dependent mechanism supports PI3K-independent chemotaxis stimulated by urokinase-type plasminogen activator
J. Cell Sci.,
February 15, 2002;
115(4):
699 - 711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Chazaud, R. Ricoux, C. Christov, A. Plonquet, R. K. Gherardi, and G. Barlovatz-Meimon
Promigratory Effect of Plasminogen Activator Inhibitor-1 on Invasive Breast Cancer Cell Populations
Am. J. Pathol.,
January 1, 2002;
160(1):
237 - 246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wei, J. A. Eble, Z. Wang, J. A. Kreidberg, and H. A. Chapman
Urokinase Receptors Promote beta 1 Integrin Function through Interactions with Integrin alpha 3beta 1
Mol. Biol. Cell,
October 1, 2001;
12(10):
2975 - 2986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B. Siconolfi and N. W. Seeds
Mice Lacking tPA, uPA, or Plasminogen Genes Showed Delayed Functional Recovery after Sciatic Nerve Crush
J. Neurosci.,
June 15, 2001;
21(12):
4348 - 4355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Koolwijk, N. Sidenius, E. Peters, C. F. M. Sier, R. Hanemaaijer, F. Blasi, and V. W. M. van Hinsbergh
Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices
Blood,
May 15, 2001;
97(10):
3123 - 3131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Degryse, T. Bonaldi, P. Scaffidi, S. Muller, M. Resnati, F. Sanvito, G. Arrigoni, and M. E. Bianchi
The High Mobility Group (HMG) Boxes of the Nuclear Protein HMG1 Induce Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells
J. Cell Biol.,
March 19, 2001;
152(6):
1197 - 1206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Kjoller and A. Hall
Rac Mediates Cytoskeletal Rearrangements and Increased Cell Motility Induced by Urokinase-type Plasminogen Activator Receptor Binding to Vitronectin
J. Cell Biol.,
March 12, 2001;
152(6):
1145 - 1158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Petty and A. L. Kindzelskii
Dissipative metabolic patterns respond during neutrophil transmembrane signaling
PNAS,
March 1, 2001;
(2001)
61014298.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. HAJ-YEHIA, T. NASSAR, B. S. SACHAIS, A. KUO, K. BDEIR, A. B. AL-MEHDI, A. MAZAR, D. B. CINES, and A. A.-R. HIGAZI
Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo
FASEB J,
July 1, 2000;
14(10):
1411 - 1422.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Farias-Eisner, L. Vician, A. Silver, S. Reddy, S. A. Rabbani, and H. R. Herschman
The Urokinase Plasminogen Activator Receptor (UPAR) Is Preferentially Induced by Nerve Growth Factor in PC12 Pheochromocytoma Cells and Is Required for NGF-Driven Differentiation
J. Neurosci.,
January 1, 2000;
20(1):
230 - 239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Webb, D. Nguyen, and S. Gonias
Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion
J. Cell Sci.,
January 1, 2000;
113(1):
123 - 134.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kusch, S. Tkachuk, H. Haller, R. Dietz, D. C. Gulba, M. Lipp, and I. Dumler
Urokinase Stimulates Human Vascular Smooth Muscle Cell Migration via a Phosphatidylinositol 3-Kinase-Tyk2 Interaction
J. Biol. Chem.,
December 8, 2000;
275(50):
39466 - 39473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mukhina, V. Stepanova, D. Traktouev, A. Poliakov, R. Beabealashvilly, Y. Gursky, M. Minashkin, A. Shevelev, and V. Tkachuk
The Chemotactic Action of Urokinase on Smooth Muscle Cells Is Dependent on Its Kringle Domain. CHARACTERIZATION OF INTERACTIONS AND CONTRIBUTION TO CHEMOTAXIS
J. Biol. Chem.,
May 26, 2000;
275(22):
16450 - 16458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. D. Nguyen, D. J. Webb, A. D. Catling, Q. Song, A. Dhakephalkar, M. J. Weber, K. S. Ravichandran, and S. L. Gonias
Urokinase-type Plasminogen Activator Stimulates the Ras/Extracellular Signal-regulated Kinase (ERK) Signaling Pathway and MCF-7 Cell Migration by a Mechanism That Requires Focal Adhesion Kinase, Src, and Shc. RAPID DISSOCIATION OF GRB2/SOS-SHC COMPLEX IS ASSOCIATED WITH THE TRANSIENT PHOSPHORYLATION OF ERK IN UROKINASE-TREATED CELLS
J. Biol. Chem.,
June 16, 2000;
275(25):
19382 - 19388.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|